Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NextCure, Inc. - Common Stock (NQ:NXTC)

4.850 -0.090 (-1.82%)
Streaming Delayed Price Updated: 1:43 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,723
Open 4.850
Bid (Size) 4.770 (3)
Ask (Size) 4.930 (1)
Prev. Close 4.940
Today's Range 4.790 - 4.900
52wk Range 2.688 - 19.20
Shares Outstanding 2,337,516
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
From NextCure
Via GlobeNewswire
NextCure (NXTC) Q2 Loss Widens 71%
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
-50.8%
-50.8%
1 Month
-6.7%
-6.7%
3 Month
-18.4%
-18.4%
6 Month
-43.3%
-43.3%
1 Year
-72.3%
-72.3%

More News

Read More
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
From NextCure
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open On A Mixed Note: Intel, Philips 66, Centene, Charter Earnings In Focus
Via Benzinga
Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment
Via Stocktwits
Nextcure Stock Skyrockets Nearly 45% In After-Hours Trading After Sharing Preclinical Data For Brittle Bone Disease
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Thursday's after hours session: top gainers and losers
Via Chartmill
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
From NextCure
Via GlobeNewswire
Monday's session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline
Via Stocktwits
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
From NextCure
Via GlobeNewswire
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
From NextCure
Via GlobeNewswire
NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
From NextCure
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
NextCure to Present at 24th Annual Needham Virtual Healthcare Conference
From NextCure
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
NextCure Provides Business Update and Reports Full Year 2024 Financial Results
From NextCure
Via GlobeNewswire
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Via Stocktwits
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is NextCure, Inc. - Common Stock publicly traded?
Yes, NextCure, Inc. - Common Stock is publicly traded.
What exchange does NextCure, Inc. - Common Stock trade on?
NextCure, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NextCure, Inc. - Common Stock?
The ticker symbol for NextCure, Inc. - Common Stock is NXTC on the Nasdaq Stock Market
What is the current price of NextCure, Inc. - Common Stock?
The current price of NextCure, Inc. - Common Stock is 4.850
When was NextCure, Inc. - Common Stock last traded?
The last trade of NextCure, Inc. - Common Stock was at 09/05/25 01:43 PM ET
What is the market capitalization of NextCure, Inc. - Common Stock?
The market capitalization of NextCure, Inc. - Common Stock is 11.34M
How many shares of NextCure, Inc. - Common Stock are outstanding?
NextCure, Inc. - Common Stock has 11M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.